Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches

MLA

Privitera, Giuseppe, et al. Novel Trends with Biologics in Inflammatory Bowel Disease: Sequential and Combined Approaches. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1330710103&authtype=sso&custid=ns315887.

APA

Privitera, G., Pugliese, D., Lopetuso, L. R., Scaldaferri, F., Neri, M., Guidi, L., Gasbarrini, A., Armuzzi, A., Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri (ORCID:0000-0001-8334-7541), Luisa Guidi (ORCID:0000-0003-3320-7094), Antonio Gasbarrini (ORCID:0000-0002-7278-4823), & Alessandro Armuzzi (ORCID:0000-0003-1572-0118). (2021). Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches.

Chicago

Privitera, Giuseppe, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri, Matteo Neri, Luisa Guidi, Antonio Gasbarrini, et al. 2021. “Novel Trends with Biologics in Inflammatory Bowel Disease: Sequential and Combined Approaches.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1330710103&authtype=sso&custid=ns315887.